CD79A and COVID-19: In this study, we measured specific IgG and IgA responses in blood and saliva, and SARS-CoV-2 neutralising activity in saliva, in SARS-CoV-2 convalescent patients and for up to 5 months in naïve and convalescent patients receiving first and second COVID-19 vaccinations.